Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.

Source:http://linkedlifedata.com/resource/pubmed/id/16382463

Download in:

View as

General Info

PMID
16382463